Drucilla Roberts

Dr. Drucilla Roberts


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2020 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
JHJonathon L. Hecht
Jonathon L. Hecht
BQBradley Quade
Bradley Quade
VDVikram Deshpande
Vikram Deshpande
MMMari Mino-Kenudson
Mari Mino-Kenudson
DTDavid T. Ting
David T. Ting
DRDrucilla Roberts
Drucilla Roberts

27 October 2021 in Science Translational Medicine
Verified
Journal Article
Open access
EBEvan A. Bordt
Evan A. Bordt
LSLydia L. Shook
Lydia L. Shook
CACaroline Atyeo
Caroline Atyeo
KPKrista M. Pullen
Krista M. Pullen
RGRose M. De Guzman
Rose M. De Guzman
AEAndrea G. Edlow
Andrea G. Edlow
Maternal SARS-CoV-2 infection drives sexually dimorphic placental immune responses and reduces SARS-CoV-2–specific antibody transfer to male fetuses.

22 December 2017 in APMIS
Verified
Journal Article
Closed access
PDF file
ACAthena Chen
Athena Chen
DRDrucilla Roberts
Drucilla Roberts


19 December 2022 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
DRDrucilla Roberts
Drucilla Roberts
RBRebecca N. Baergen
Rebecca N. Baergen
TBTheonia K. Boyd
Theonia K. Boyd
CCChrystalle Katte Carreon
Chrystalle Katte Carreon
VDVirginia E. Duncan
Virginia E. Duncan
ECEumenia C. Castro
Eumenia C. Castro
Pathologic examination of the placenta can provide insight into likely (and unlikely) causes of antepartum and intrapartum events, diagnoses with urgent clinical relevance, prognostic information for mother and infant, support for practice evaluation and improvement, and insight into advancing the sciences of obstetrics and neonatology. Although it is true that not all placentas require pathologic examination (although alternative opinions have been expressed), prioritization of placentas for pathologic examination should be based on vetted indications such as maternal comorbidities or pregnancy complications in which placental pathology is thought to be useful for maternal or infant care, understanding pathophysiology, or practice modifications. Herein we provide placental triage criteria for the obstetrical and neonatal provider based on publications and expert opinion of 16 placental pathologists and a pathologists' assistant, formulated using a modified Delphi approach. These criteria include indications in which placental pathology has clinical relevance, such as pregnancy loss, maternal infection, suspected abruption, fetal growth restriction, preterm birth, nonreassuring fetal heart testing requiring urgent delivery, preeclampsia with severe features, or neonates with early evidence of multiorgan system failure including neurologic compromise. We encourage a focused gross examination by the provider or an attendant at delivery for all placentas and provide guidance for this examination. We recommend that any placenta that is abnormal on gross examination undergo a complete pathology examination. In addition, we suggest practice criteria for placental pathology services, including a list of critical values to be used by the relevant provider. We hope that these sets of triage indications, criteria, and practice suggestions will facilitate appropriate submission of placentas for pathologic examination and improve its relevance to clinical care.

1 December 2020 in Human Pathology
Verified
Journal Article
Closed access
SMSara Makhdoum
Sara Makhdoum
VNValentina Nardi
Valentina Nardi
KDKelly A. Devereaux
Kelly A. Devereaux
CKChristian A. Kunder
Christian A. Kunder
GNGunnlaugur Petur Nielsen
Gunnlaugur Petur Nielsen
DRDrucilla Roberts
Drucilla Roberts